Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 10 |
| List of Tables | 10 | 3 |
| List of Figures | 13 | 2 |
| Introduction | 15 | 1 |
| GBI Research Guidance | 15 | 1 |
| Global Cardiovascular Devices - Market Characterization | 16 | 9 |
| Global Cardiovascular Devices Market, Revenue ($bn), 2003-2010 | 16 | 1 |
| Global Cardiovascular Devices Market, Revenue ($bn), 2010-2017 | 17 | 1 |
| Global Cardiovascular Devices Market, Key Company Shares (%), 2010 | 18 | 1 |
| Global Cardiovascular Devices Market, Key Trends | 19 | 1 |
| Industry Consolidation Taking Place in Cardiovascular Devices Market through Mergers and Acquisitions is Changing the Competitive Landscape | 19 | 1 |
| Cardiovascular Diseases Continue to be the Number One Cause of Death Worldwide | 20 | 1 |
| The Increased use of Percutaneous Coronary Intervention (PCI) Compared to Coronary Artery Bypass Grafts (CABG) Continues to Drive the Cardiovascular Devices Market Growth | 20 | 1 |
| Global Cardiovascular Devices, Market Dynamics | 21 | 1 |
| Market Drivers | 21 | 1 |
| Growing Patient Pool Due to Increasing Elderly Population to Drive the Growth in Cardiovascular Devices Market | 21 | 1 |
| Lifestyle Diseases Such as Diabetes, Obesity, High Blood Pressure and High Cholesterol to Drive the Cardiovascular Devices Market | 22 | 1 |
| Technological Innovation and Minimally Invasive Procedures to Drive the Cardiovascular Devices Market | 23 | 1 |
| Market Restraints | 24 | 1 |
| High Cost of Cardiovascular Devices Negatively Affect Growth of the Cardiovascular Devices Market | 24 | 1 |
| Global Cardiovascular Devices Market - Category Analysis and Forecasts | 25 | 53 |
| Cardiac Rhythm Management Devices | 25 | 1 |
| Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2003-2010 | 25 | 1 |
| Cardiac Rhythm Management Market, Global, Revenue ($m), 2010-2017 | 26 | 1 |
| Cardiac Rhythm Management Market, Global, Key Company Shares (%), 2010 | 27 | 1 |
| Cardiac Rhythm Management - Market Dynamics | 28 | 1 |
| Market Drivers | 28 | 1 |
| Miniaturization and Technological Innovations Such as MRI Compatible Pacemakers to Propel the Growth of the Cardiac Rhythm Management (CRM) Market | 28 | 1 |
| Increase in Application of Cardiac Resynchronization Therapy (CRT) to Drive the Cardiac Rhythm Management Market | 28 | 1 |
| Increased Number of Replacement Procedures is Driving Revenue Generation for Manufacturers | 29 | 1 |
| Market Restraints | 29 | 1 |
| Affordability and Limited Penetration of Pacemakers in Emerging Countries Such as India to Adversely Affect Procedure Volumes | 29 | 1 |
| Interventional Cardiology | 30 | 1 |
| Interventional Cardiology, Global, Revenue ($m), 2003-2010 | 30 | 2 |
| Interventional Cardiology Market, Global, Revenue ($m), 2010-2017 | 32 | 1 |
| Interventional Cardiology Market, Global, Key Company Shares (%), 2010 | 33 | 1 |
| Interventional Cardiology - Market Dynamics | 34 | 1 |
| Market Drivers | 34 | 1 |
| Innovative Devices and Technological Advancement to Drive the Growth of Interventional Cardiology Market | 34 | 1 |
| Ease of Use and Advantages over Drug Eluting Stents to Drive the Demand for Drug Eluting Balloons | 35 | 1 |
| Market Restraints | 36 | 1 |
| CABG is Still the Preferred Choice for the treatment of Triple Vessel Blockages and Bifurcation Lesions over PCI. | 36 | 1 |
| Re-stenosis Acting as a Deterrent to the Increased Uptake of Coronary Stent Volumes | 36 | 1 |
| Peripheral Vascular Devices | 37 | 1 |
| Peripheral Vascular Devices Market, Global, Revenue ($m), 2003-2010 | 37 | 2 |
| Peripheral Vascular Devices Market, Global, Revenue ($m), 2010-2017 | 39 | 2 |
| Peripheral Vascular Devices Market, Global, Key Company Shares (%), 2010 | 41 | 1 |
| Peripheral Vascular Devices - Market Dynamics | 42 | 1 |
| Market Drivers | 42 | 1 |
| Increasing Prevalence of Peripheral Vascular Disease (PVD) due to Increasing Occurrence of High Risk Factors to Drive Demand for Peripheral Vascular Devices | 42 | 1 |
| Device Innovation and Technological Advances to Drive Peripheral Vascular Devices Market Growth | 42 | 1 |
| Market Restraints | 43 | 1 |
| Lack of Adequate Reimbursement for DEBs to Slow Down the Physician Adoption | 43 | 1 |
| Cardiovascular Surgery Devices | 44 | 1 |
| Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2003-2010 | 44 | 1 |
| Cardiovascular Surgery Devices Market, Global, Revenue Forecasts ($m), 2010-2017 | 45 | 1 |
| Cardiovascular Surgery Devices Market, Global, Key Company Shares (%), 2010 | 46 | 1 |
| Cardiovascular Surgery Devices - Market Dynamics | 47 | 1 |
| Market Drivers | 47 | 1 |
| Minimally Invasive Procedures to Propel the Growth of Cardiovascular Surgery Market | 47 | 1 |
| Preference to Cardiovascular Surgery over Newer Techniques Such as PCI to Drive the Growth of the Cardiovascular Surgery Market | 47 | 1 |
| Market Restraints | 47 | 1 |
| Increased Adoption of Minimally Invasive Procedures Such as Percutaneous Coronary Interventions to Slow the Cardiovascular Surgery Devices Market Growth | 47 | 1 |
| Prosthetic Heart Valves | 48 | 1 |
| Prosthetic Heart Valves Market, Global, Revenue ($m), 2003-2010 | 48 | 1 |
| Prosthetic Heart Valves Market, Global, Revenue ($m), 2010-2017 | 49 | 1 |
| Prosthetic Heart Valves Market, Global, Key Company Shares (%), 2010 | 50 | 1 |
| Prosthetic Heart Valves - Market Dynamics | 51 | 1 |
| Market Drivers | 51 | 1 |
| Less-Invasive Technology such as Transcatheter Aortic Heart Valve Replacement (TAVR) Will Drive the Growth of the Prosthetic Heart Valves Market | 51 | 1 |
| Increasing Elderly Population with Rheumatic Disease in Developed and Developing Nations to Sustain Demand for Heart Valve Replacement Procedures | 51 | 1 |
| Increased Adoption of Tissue Heart Valves in Developed and Emerging Countries is Driving the Growth of the Prosthetic Heart Valves Market | 51 | 1 |
| Market Restraints | 52 | 1 |
| Complications Associated with Prosthetic Heart Valve Replacement Procedures to Adversely Affect the Growth of the Prosthetic Heart Valves Market | 52 | 1 |
| External Defibrillators | 53 | 1 |
| External Defibrillators, Global, Revenue ($m), 2003-2010 | 53 | 1 |
| External Defibrillators, Global, Revenue ($m), 2010-2017 | 54 | 1 |
| External Defibrillators, Global, Key Company Shares (%), 2010 | 55 | 1 |
| External Defibrillators - Market Dynamics | 56 | 1 |
| Market Drivers | 56 | 1 |
| Increasing Incidence of Sudden Cardiac Arrest (SCA) and Ventricular Fibrillation is Spurring the Demand for External Defibrillators. | 56 | 1 |
| The Short Expiry Period of External Defibrillators Leading to the Need for Re-installations will Drive the Market | 56 | 1 |
| Market Restraints | 57 | 1 |
| High Price of External Defibrillators Acts as a Major Restraint to Market Penetration | 57 | 1 |
| Electrophysiology | 58 | 1 |
| Electrophysiology, Global, Revenue ($m), 2003-2010 | 58 | 1 |
| Electrophysiology, Global, Revenue ($m), 2010-2017 | 59 | 1 |
| Electrophysiology, Global, Key Company Shares (%), 2010 | 60 | 1 |
| Electrophysiology - Market Dynamics | 61 | 1 |
| Market Drivers | 61 | 1 |
| Increasing Adoption of Ablation Techniques for the Treatment of Atrial Fibrillation to Drive the Growth of the Electrophysiology Market | 61 | 1 |
| Innovative Products and Technological Advances to Boost the Electrophysiology Market | 61 | 1 |
| Market Restraints | 62 | 1 |
| Increasing Use of Refurbished Electrophysiology Diagnostic Catheters is a Restraint to Market Growth | 62 | 1 |
| Inadequate Access to Cardiac Electrophysiologists to Negatively Affect the Procedure Volumes and Slow Down Market Growth | 63 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices | 64 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2003-2010 | 64 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue Forecast ($m), 2010-2017 | 65 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company Shares (%), 2010 | 66 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices - Market Dynamics | 67 | 1 |
| Market Drivers | 67 | 1 |
| Increasing Incidence of Cardiovascular Diseases to Drive the Demand for Cardiovascular Diagnostic and Monitoring Devices | 67 | 1 |
| Innovative Devices to Drive the Demand for Cardiovascular Monitoring and Diagnostic Devices | 67 | 1 |
| Emerging Countries to Drive the Growth of the Cardiovascular Monitoring and Diagnostic Devices Market | 68 | 1 |
| Market Restraints | 68 | 1 |
| Shift to Low Cost Devices to Effect the Revenue Growth of the Companies | 68 | 1 |
| Cardiac Assist Devices | 69 | 1 |
| Cardiac Assist Devices Market, Global, Revenue ($m), 2003-2010 | 69 | 1 |
| Cardiac Assist Devices Market, Global, Revenue ($m), 2010-2017 | 70 | 1 |
| Cardiac Assist Devices Market, Global, Key Company Shares (%), 2010 | 71 | 1 |
| Cardiac Assist Devices - Market Dynamics | 72 | 1 |
| Market Drivers | 72 | 1 |
| Increase in Percentage of People Suffering From Congestive Heart Failure to Drive the Demand for Cardiac Assist Devices | 72 | 1 |
| Device Innovation in the Cardiac Assist Devices Market is Expected to Drive Future Adoption Rates | 72 | 1 |
| Market Restraints | 73 | 1 |
| Complications Associated with the Use of Cardiac Assist Devices to Negatively Affect the Adoption Rate of Cardiac Assist Devices | 73 | 1 |
| Cardiovascular Prosthetic Devices | 74 | 1 |
| Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2003-2010 | 74 | 1 |
| Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2010-2017 | 75 | 1 |
| Cardiovascular Prosthetic Devices Market, Global, Key Company Shares (%), 2010 | 76 | 1 |
| Cardiovascular Prosthetic Devices - Market Dynamics | 77 | 1 |
| Market Drivers | 77 | 1 |
| Less Invasive Nature of Septal Occluders will Drive the Adoption Rate of these Devices | 77 | 1 |
| Market Restraints | 77 | 1 |
| Adverse Effects Associated with Transcatheter Closure of ASDs to Deter Market Growth | 77 | 1 |
| Global Cardiovascular Devices Market - Country Analysis and Forecasts | 78 | 41 |
| Cardiovascular Devices Market - Cross-Country Analysis | 78 | 2 |
| Historic (2003-2010) and Forecast (2010-2017) Revenue, By Country | 80 | 1 |
| Cardiovascular Devices Market, The US, Revenue ($m), 2003-2010 | 80 | 2 |
| Cardiovascular Devices Market, The US, Revenue ($m), 2010-2017 | 82 | 2 |
| Cardiovascular Devices Market, Canada, Revenue ($m), 2003-2010 | 84 | 1 |
| Cardiovascular Devices Market, Canada, Revenue ($m), 2010-2017 | 85 | 1 |
| Cardiovascular Devices Market, The UK, Revenue ($m), 2003-2010 | 86 | 1 |
| Cardiovascular Devices Market, The UK, Revenue ($m), 2010-2017 | 87 | 2 |
| Cardiovascular Devices Market, Germany, Revenue ($m), 2003-2010 | 89 | 2 |
| Cardiovascular Devices Market, Germany, Revenue, ($m), 2010-2017 | 91 | 2 |
| Cardiovascular Devices Market, France, Revenue ($m), 2003-2010 | 93 | 2 |
| Cardiovascular Devices Market, France, Revenue Forecast ($m), 2010-2017 | 95 | 2 |
| Cardiovascular Devices Market, Italy, Revenue ($m), 2003-2010 | 97 | 2 |
| Cardiovascular Devices Market, Italy, Revenue Forecast ($m), 2010-2017 | 99 | 2 |
| Cardiovascular Devices Market, Spain, Revenue ($m), 2003-2010 | 101 | 1 |
| Cardiovascular Devices Market, Spain, Revenue ($m), 2010-2017 | 102 | 2 |
| Cardiovascular Devices Market, Japan, Revenue ($m), 2003-2010 | 104 | 2 |
| Cardiovascular Devices Market, Japan, Revenue Forecast ($m), 2010-2017 | 106 | 2 |
| Cardiovascular Devices Market, China, Revenue ($m), 2003-2010 | 108 | 2 |
| Cardiovascular Devices Market, China, Revenue Forecast ($m), 2010-2017 | 110 | 2 |
| Cardiovascular Devices Market, India, Revenue ($m), 2003-2010 | 112 | 1 |
| Cardiovascular Devices Market, India, Revenue Forecast ($m), 2010-2017 | 113 | 1 |
| Cardiovascular Devices Market, Australia, Revenue ($m), 2003-2010 | 114 | 2 |
| Cardiovascular Devices Market, Australia, Revenue ($m), 2010-2017 | 116 | 1 |
| Cardiovascular Devices Market, Brazil, Revenue ($m), 2003-2010 | 117 | 1 |
| Cardiovascular Devices Market, Brazil, Revenue ($m), 2010-2017 | 118 | 1 |
| Global Cardiovascular Devices Market - Competitive Assessment | 119 | 9 |
| Boston Scientific Corporation | 120 | 1 |
| Overview | 120 | 1 |
| Key Marketed Products | 121 | 1 |
| Medtronic, Inc | 121 | 1 |
| Business Overview | 121 | 1 |
| Key Marketed Products | 122 | 1 |
| St. Jude Medical, Inc. | 122 | 1 |
| Business Overview | 122 | 1 |
| Key Marketed Products | 122 | 1 |
| Abbott Laboratories | 123 | 1 |
| Business Overview | 123 | 1 |
| Key Marketed Products | 123 | 1 |
| Cordis | 124 | 1 |
| Business Overview | 124 | 1 |
| Key Marketed Products | 124 | 1 |
| Terumo Corporation | 124 | 1 |
| Business Overview | 124 | 1 |
| Key Marketed Products | 124 | 1 |
| Sorin Group | 125 | 1 |
| Business Overview | 125 | 1 |
| Key Marketed Products | 125 | 1 |
| Phillips Healthcare | 125 | 1 |
| Business Overview | 125 | 1 |
| Key Marketed Products | 125 | 1 |
| Edwards Lifesciences Corporation | 126 | 1 |
| Business Overview | 126 | 1 |
| Key Marketed Products | 126 | 1 |
| C.R. Bard, Inc. | 126 | 1 |
| Business Overview | 126 | 1 |
| Key Marketed Products | 126 | 1 |
| Biosense Webster, Inc. | 126 | 1 |
| Business Overview | 126 | 1 |
| Key Marketed Products | 126 | 1 |
| BIOTRONIK SE &Co. KG | 127 | 1 |
| Business Overview | 127 | 1 |
| Key Marketed Products | 127 | 1 |
| Global Cardiovascular Devices Market - Product Pipeline Analysis | 128 | 70 |
| Interventional Cardiology | 128 | 1 |
| Interventional Cardiology - List of Pipeline Products | 129 | 8 |
| Profiles of Key Pipeline Products - Interventional cardiology | 137 | 1 |
| Coronary Stents | 137 | 1 |
| Absorb | 137 | 1 |
| AVJ-09-385 | 137 | 1 |
| Bifurcated DES | 138 | 1 |
| OMEGA Platinum Chromium Coronary Stent | 138 | 1 |
| PTCA Balloons | 138 | 1 |
| Avion Bifurcation RX2 | 138 | 1 |
| NC Zulu PTCA Post-Dil | 139 | 1 |
| Cardiac Catheters | 139 | 1 |
| FiberHalo SRM Pre-Dilation Angioplasty Catheter | 139 | 1 |
| Coronary Guidewires | 140 | 1 |
| Wrist Artery Guidewire | 140 | 1 |
| Coronary Guidewire | 140 | 1 |
| Arteriotomy Closure Devices | 140 | 1 |
| FastSeal Bioabsorbable Vascular Access Closure System | 140 | 1 |
| Intravascular Ultra Sound System | 141 | 1 |
| jLab System + 3.0 Software | 141 | 1 |
| VALET Micro-Catheter | 141 | 1 |
| PTCA Coronary Drug Eluting Balloons (DEB) | 141 | 1 |
| IN.PACT Falcon PTCA Balloon Catheter | 141 | 1 |
| Peripheral Vascular Devices | 142 | 1 |
| Peripheral Vascular Devices - List of Pipeline Products | 143 | 7 |
| Profiles of Key Pipeline Products - Peripheral Vascular Devices | 150 | 1 |
| Peripheral Vascular Stents | 150 | 1 |
| WallFlex Biliary RX Fully Covered Stent - Benign Biliary Strictures | 150 | 1 |
| Pulsar-80 Stent | 151 | 1 |
| Stent Grafts | 151 | 1 |
| Amplatzer AAA Vascular Graft | 151 | 1 |
| INCRAFT AAA Stent Graft | 151 | 1 |
| PTA Balloons | 152 | 1 |
| POWERFLEX Pro PTA Balloon | 152 | 1 |
| Synthetic Surgical Grafts | 152 | 1 |
| Next Generation Stent Graft | 152 | 1 |
| Fusion Vascular Access Graft | 152 | 1 |
| Inferior Vena Cava Filters (IVCF) | 153 | 1 |
| Bard Denali Retrievable Inferior Vena Cava Filter System | 153 | 1 |
| Angel Vena Cava Filter Catheter | 153 | 1 |
| Peripheral Embolic Protection Devices | 153 | 1 |
| Embrella Embolic Deflector System | 153 | 1 |
| Peripheral Guidewires | 154 | 1 |
| Skipper Deep | 154 | 1 |
| PTA Peripheral Drug Eluting Balloons (DEB) | 154 | 1 |
| Passeo-18 Lux | 154 | 1 |
| Boston Drug Eluting Balloon | 154 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices | 155 | 1 |
| Cardiovascular Monitoring and Diagnostic Devices - List of Pipeline Products | 156 | 3 |
| Profiles of Key Pipeline Products - Cardiovascular Monitoring and Diagnostic Devices | 159 | 1 |
| ECG Monitoring Equipment | 159 | 1 |
| 24/7 WiFi ECG Monitor | 159 | 1 |
| Heartscape 3D ECG System with 80-Lead Vest | 159 | 1 |
| Holter Monitoring Systems | 160 | 1 |
| Aingeal Wireless Holter Monitor | 160 | 1 |
| Cardiopulmonary Stress Testing Systems | 160 | 1 |
| Diagnostic Test - Pulmonary Arterial Hypertension | 160 | 1 |
| Event Monitoring Systems | 161 | 1 |
| Blue Scale | 161 | 1 |
| Cardiac Assist Devices | 162 | 1 |
